Release Date: 16/12/08 18:19 Summary: Response to ASX Query - Director's Interest Notices Price Sensitive: No Download Document 64.2KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%